Ask AI
Second-line Pirtobrutinib in CLL/SLL After Covalent BTKi Treatment: A Pooled Analysis of BRUIN LOXO-BTK18001 and BRUIN CLL-321

Activity

Progress
1
Course Completed
Activity Information

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit™

Released: March 30, 2026

Expiration: September 29, 2026